Trait
Astrocytoma
Astrocytoma is a neoplasm of the central nervous system derived from astrocytes. Astrocytes are a type of glial cell, and thus astrocytoma is a subtype of glioma.
Summary
This page as data
Add .json to the page's address, or ask for application/json, to read it as JSON.
library(jsonlite)
url <- "https://dantelabs.com/traits/astrocytoma.json"
page <- fromJSON(url)
page$trait$nameRead the genes linked to Astrocytoma, and the rest of your genome, with one test.
From $449Free shipping · Results in 6–8 weeks
Get my Genome Test25 genes linked to Astrocytoma
Changes in these genes cause rare conditions in which Astrocytoma is seen. Most people with this trait have none of those conditions, and a gene on this list says nothing about anyone's own genome.
| Gene | How often it is seen | Conditions |
|---|---|---|
| MLH1mutL homolog 1 | Very often (80–99%) | In 1 condition |
| FGFR1fibroblast growth factor receptor 1 | Often (30–79%) | In 1 condition |
| MSH3mutS homolog 3 | Often (30–79%) | In 2 conditions |
| MSH6mutS homolog 6 | Often (30–79%) | In 1 condition |
| PMS2PMS1 homolog 2, mismatch repair system component | Often (30–79%) | In 1 condition |
| APCAPC regulator of Wnt signaling pathway | Sometimes (5–29%) | In 3 conditions |
| BRCA2BRCA2 DNA repair associated | Sometimes (5–29%) | In 1 condition |
| CDKN2Acyclin dependent kinase inhibitor 2A | Sometimes (5–29%) | In 2 conditions |
| CHEK2checkpoint kinase 2 | Sometimes (5–29%) | In 1 condition |
| IDH1isocitrate dehydrogenase (NADP(+)) 1 | Sometimes (5–29%) | In 2 conditions |
| IDH2isocitrate dehydrogenase (NADP(+)) 2 | Sometimes (5–29%) | In 1 condition |
| MDM2MDM2 proto-oncogene | Sometimes (5–29%) | In 1 condition |
| TP53tumor protein p53 | Sometimes (5–29%) | In 2 conditions |
| APC2APC regulator of Wnt signaling pathway 2 | Rarely (1–4%) | In 1 condition |
| CCM2CCM2 scaffold protein | Rarely (1–4%) | In 1 condition |
| KRIT1KRIT1 ankyrin repeat containing | Rarely (1–4%) | In 1 condition |
| NF1neurofibromin 1 | Rarely (1–4%) | In 1 condition |
| NF2NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor | Rarely (1–4%) | In 2 conditions |
| NSD1nuclear receptor binding SET domain protein 1 | Rarely (1–4%) | In 1 condition |
| PDCD10programmed cell death 10 | Rarely (1–4%) | In 1 condition |
| PIK3CAphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | Rarely (1–4%) | In 1 condition |
| ERBB2erb-b2 receptor tyrosine kinase 2 | Not recorded | In 1 condition |
| IFNGinterferon gamma | Not recorded | In 1 condition |
| TSC1TSC complex subunit 1 | Not recorded | In 1 condition |
| TSC2TSC complex subunit 2 | Not recorded | In 1 condition |
How often is among people with one of the gene's conditions, the most often across them, as the Human Phenotype Ontology records it. These pages describe traits and the research behind them; they are not a diagnosis, and a doctor or genetic counsellor is the person to ask about symptoms.
Narrower traits
Broader traits
Where this comes from
- The Human Phenotype Ontology, release 2026-09-01: the trait, its names, its definition and the genes linked to it. Find out more at hpo.jax.org.
- Data release 2026.10.16-c6eea6bf.
One test. A lifetime of answers.
From $449Free shipping · Results in 6–8 weeks